- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure ; day:4 ; month:11 ; year:2020 ; pages:1-20
Heart failure reviews ; (4.11.2020), 1-20
- Creator
-
Dutka, Mieczysław
Bobiński, Rafał
Ulman-Włodarz, Izabela
Hajduga, Maciej
Bujok, Jan
Pająk, Celina
Ćwiertnia, Michał
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10741-020-10041-1
- URN
-
urn:nbn:de:101:1-2020121721054202002885
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dutka, Mieczysław
- Bobiński, Rafał
- Ulman-Włodarz, Izabela
- Hajduga, Maciej
- Bujok, Jan
- Pająk, Celina
- Ćwiertnia, Michał
- SpringerLink (Online service)
Other Objects (12)
Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care